1.Short-term Effect of Partially Hydrolyzed Formula on the Prevention of Development of Atopic Dermatitis in Infants at High Risk.
Young Shin HAN ; Hwa Young PARK ; Kang Mo AHN ; Ju Seok LEE ; Hay Mie CHOI ; Sang Il LEE
Journal of Korean Medical Science 2003;18(4):547-551
This short-term, prospective study was aimed to assess the effects of partially hydrolyzed formula (PHF) on the prevention of the development of atopic dermatitis in infants at high risk. The infants of parents with allergy symptoms and serum total IgE over 200 kU/L were divided into 3 groups by their feeding patterns: PHF group (n=15), standard formula (SF) group (n=32), and breast milk (BM) group (n=22). No allergenic food was given during the study period of 6 months, and breastfeeding mothers avoided egg ingestion. Their atopic symptoms were monitored every 2 months. The cumulative incidence and prevalence of atopic dermatitis at the age of 6 months were significantly less in the PHF group than in the SF group (47% vs.78%, p<0.05; 20% vs. 59%, p<0.05). Those rates of the PHF group were also less than those of the BM group, but they were not statistically significant. There was no difference in the onset age and disease severity. These results suggest that early feeding of PHF to infants at high risk has a short-term preventive effect on the development of atopic dermatitis during the first 6 months of life. Long-term preventive effects should be evaluated.
Breast Feeding
;
Dermatitis, Atopic/*etiology/*prevention & control
;
Electrophoresis, Polyacrylamide Gel
;
Female
;
Food Hypersensitivity
;
Human
;
Hydrolysis
;
Hypersensitivity
;
Immunoglobulin E/blood
;
Infant
;
*Infant Food
;
Infant, Newborn
;
Male
;
Milk, Human
;
Prospective Studies
;
Protein Hydrolysates/*therapeutic use
;
Risk
;
Time Factors
2.Clinical observation on scalp point injection to improve the cerebral microcirculation for children of early cerebral palsy.
Chinese Acupuncture & Moxibustion 2009;29(10):795-798
OBJECTIVETo explore an effective therapy for children of early cerebral palsy.
METHODSOne hundred and twenty cases were randomly divided into an acupoint injection group and a medication group, 60 cases in each group. The acupoint injection group was treated with scalp point injection of 0.5-1 mL brain protein hydrolysate into each point, Baihui (GV 20), Fengchi (GB 20) and motor area etc. were selected; the medication group was treated with 10 mL brain protein hydrolysate by intravenous drip. The therapeutic effects in the two groups were observed, and the changes of cerebral blood flow were compared before and after treatment.
RESULTSThe total effective rate of 91.4% in the acupoint injection group was superior to that of 73.7% in the medication group (P<0.05), the acupoint injection group could significantly improve the systolic peak velocity (Vs), end diastolic velocity (Ved) and mean velocity (Vm) of middle cerebral artery (MCA) and anterior cerebral artery (ACA), and decrease the vascular resistance index (RI) (all P<0.05), and the improvement degree was superior to the medication group (all P<0.05).
CONCLUSIONScalp point injection therapy can significantly improve the cerebral microcirculation of patients, and has a good therapeutic effect for early cerebral palsy.
Acupuncture Points ; Cerebral Palsy ; drug therapy ; physiopathology ; Cerebrovascular Circulation ; drug effects ; Child ; Drugs, Chinese Herbal ; administration & dosage ; Female ; Humans ; Injections ; Male ; Protein Hydrolysates ; therapeutic use ; Scalp ; blood supply ; drug effects ; physiopathology